7 September 2018 in American Journal of Epidemiology
Postconcussive symptoms are believed to resolve in days or months in most instances for civilian injuries, though recent evidence suggests that recovery may be slower for injuries sustained during military deployment. The present study is based on a cohort of recently deployed soldiers from two US Army military bases (Fort Carson and Fort Bragg, followed from 2009-2015). Soldiers with and without a recent history of a deployment mild traumatic brain injury (mTBI) were evaluated within days of return and at 3, 6, and 12-months. Those with mTBI were more likely than non-mTBI to endorse one or more postconcussive symptoms at a severe and or very severe level (47% vs. 21% baseline; aRR=1.7 95% CI: 1.51,1.93 all-time points) and remained significant after adjusting for PTSD (aRR=1.34 95%CI: 1.41,1.82). Prevalence and relative risks (for three of most common baseline symptoms remained constant over time: sleep problems (RR=2.19), forgetfulness (RR=2.56), irritability (RR=2.73). The pattern was slightly different for headache, decreasing from RR=3.44 at baseline to RR=3.26 at 12 months, due to increased prevalence of headache in those without mTBI. . The prevalence of clinically relevant postconcussive symptoms remained relatively constant over one year of follow-up, whether or not symptoms were associated with concussion. Service members with recent mTBI reported more symptoms than non-mTBI at all time-points.
1 January 2016 in Journal of Environmental and Public Health
Background.To examine whether the US EPA (2010) lung cancer risk estimate derived from the high arsenic exposures (10–934 µg/L) in southwest Taiwan accurately predicts the US experience from low arsenic exposures (3–59 µg/L).Methods. Analyses have been limited to US counties solely dependent on underground sources for their drinking water supply with median arsenic levels of ≥3 µg/L.Results. Cancer risks (slopes) were found to be indistinguishable from zero for males and females. The addition of arsenic level did not significantly increase the explanatory power of the models. Stratified, or categorical, analysis yielded relative risks that hover about 1.00. The unit risk estimates were nonpositive and not significantly different from zero, and the maximum (95% UCL) unit risk estimates for lung cancer were lower than those in US EPA (2010).Conclusions. These data do not demonstrate an increased risk of lung cancer associated with median drinking water arsenic levels in the range of 3–59 µg/L. The upper-bound estimates of the risks are lower than the risks predicted from the SW Taiwan data and do not support those predictions. These results are consistent with a recent metaregression that indicated no increased lung cancer risk for arsenic exposures below 100–150 µg/L.